Document is current
Any future updates will be listed below
-
Authors
Freeman, Emily
Langlois, Stéphanie
Leyba, Marcos F.
Ammar, Tarek
Léger, Zacharie
McMillan, Hugh J.
Renaud, Jean-Marc
Jasmin, Bernard J.
Cowan, Kyle N.
-
Funding
Funding for this research was provided by:
Queen Elizabeth II Graduate Scholarship in Science and Technology
Dr. Alex Mackenzie Trainee Grant
Association Française contre les Myopathies (23635, 23635)
CIHR Institute of Musculoskeletal Health and Arthritis (MHM - 184012, MHM - 184012)
Department of Surgery at the Children’s Hospital of Eastern Ontario
Children’s Hospital of Eastern Ontario Research Institute
- License Information
-
More Information
Article History
Received: 14 August 2023
Accepted: 3 April 2024
First Online: 26 April 2024
Declarations
:
: After institutional ethics board approval (CHEO (Children’s Hospital of Eastern Ontario) Research Ethics Board, protocol #19/49X), tissue samples were obtained, as secondary use of clinical samples, from the archived specimens of the Department of Pathology and Laboratory Medicine at CHEO, Ottawa, Ontario, Canada. Experiments were carried out in accordance with the CHEO Research Ethics Board guidelines and regulations and in keeping with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.All experiments with mice were conducted in accordance with the University of Ottawa Animal Care Guidelines and the Canadian Council of Animal Care Guidelines under the experimental protocol CHEOe-3685 (protocol approved by the uOttawa Animal Care Committee).
: Not applicable.
: No conflict of interest is declared.
